These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16791802

  • 21. FDG avidity and PET/CT patterns in primary gastric lymphoma.
    Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, Gaitini D, Israel O.
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
    [Abstract] [Full Text] [Related]

  • 22. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
    Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L.
    Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
    [Abstract] [Full Text] [Related]

  • 23. [18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas].
    Khodzhibekova MM, Tiutin LA, Kostenikov NA, Il'in NV, Vinogradova IuN.
    Vestn Rentgenol Radiol; 2015 Sep; (1):16-21. PubMed ID: 25864360
    [Abstract] [Full Text] [Related]

  • 24. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 25. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
    Querellou S, Valette F, Bodet-Milin C, Oudoux A, Carlier T, Harousseau JL, Chatal JF, Couturier O.
    Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
    [Abstract] [Full Text] [Related]

  • 26. 18F-FDG PET/CT and primary hepatic MALT: a case series.
    Albano D, Giubbini R, Bertagna F.
    Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
    Altamirano J, Esparza JR, de la Garza Salazar J, Calvo PS, Vera SR, Chalapud Revelo JR, Estrada G.
    Arch Med Res; 2008 Jan; 39(1):69-77. PubMed ID: 18067998
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H.
    Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
    [Abstract] [Full Text] [Related]

  • 33. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A.
    Br J Cancer; 2001 Nov 16; 85(10):1462-6. PubMed ID: 11720429
    [Abstract] [Full Text] [Related]

  • 34. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
    Zhang WD, Guan YB, Li CX, Huang XB, Zhang FJ.
    J Comput Assist Tomogr; 2011 Nov 16; 35(5):608-13. PubMed ID: 21926857
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L, Chen Y, Wu J.
    Hell J Nucl Med; 2013 Nov 16; 16(3):230-6. PubMed ID: 24137577
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
    Hoffmann M, Kletter K, Becherer A, Jäger U, Chott A, Raderer M.
    Oncology; 2003 Nov 16; 64(4):336-40. PubMed ID: 12759529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.